Sharechat Logo

TSB Bank credit outlook raised to 'stable' by S&P on reduced property market risk

Friday 27th June 2014

Text too small?

TSB Bank, the Taranaki community-owned bank, had its credit outlook raised to "stable" from "negative" by ratings agency Standard & Poor's because of its reduced exposure to risks in the residential property market.

"The revision of the outlook from negative to stable reflects our belief that increasing risks relating to asset price inflation in the property market and high consumer leverage across New Zealand no longer represent material risks for the bank," S&P credit analyst Andrew Mayes said in a statement.

TSB has only a "modest" exposure to the high property price inflation markets of Auckland and Christchurch and a low loan-to-value ratio position across its lending portfolios, S&P said.

"As a result, we believe the bank has a substantial buffer for absorbing a modest retrace in residential property prices without a resultant increase in credit costs," S&P said. "The stable outlook reflects our belief that the bank's asset-quality would not be materially negatively affected by a limited correction in New Zealand's property market."

S&P affirmed its BBB+ long-term and A2 short term investment grade credit ratings for the bank.

 

 

 

BusinessDesk.co.nz



  General Finance Advertising    

Comments from our readers

No comments yet

Add your comment:
Your name:
Your email:
Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

December 27th Morning Report
FBU - Fletcher Building Announces Director Appointment
December 23rd Morning Report
MWE - Suspension of Trading and Delisting
EBOS welcomes finalisation of First PWA
CVT - AMENDED: Bank covenant waiver and trading update
Gentrack Annual Report 2024
December 20th Morning Report
Rua Bioscience announces launch of new products in the UK
TEM - Appointment to the Board of Directors